Category: Candel Therapeutics

Comprehensive Market Tracking Tool

In the dynamic world of biotechnology investment, keeping abreast of market trends and making informed decisions based on accurate, real-time data is not just an option—it’s a necessity. Enter TradingView, a comprehensive platform that offers a powerful solution for investors interested in tracking the pulse of various markets, from stocks and cryptocurrencies to commodities. With […]

Candel Therapeutics Adds Maha Radhakrishnan, M.D. to Board

Candel Therapeutics, a clinical-stage biopharmaceutical company with significant focus on developing multimodal biological immunotherapies for cancer patients, has recently announced the appointment of Maha Radhakrishnan, M.D., to its Board of Directors. This move aligns with the company’s strategic roadmap, which emphasizes innovative research, product development, and effective commercialization of treatment options for patients grappling with […]